Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females
This study has been terminated.
( Increased LFTs )
Study NCT00787618 Information provided by Repros Therapeutics Inc.
First Received on November 6, 2008. Last Updated on August 25, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
50mg of Proellex®
Sponsors listed in this trial
Repros Therapeutics Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers